JD Health (06618) Reports Interim Results with Revenue Up 24.5% to RMB 35.29 Billion

Stock News
08/14

JD Health (06618) announced its interim results for the six months ended June 30, 2025, with the group achieving revenue of RMB 35.29 billion, representing a year-on-year increase of 24.5%. Non-IFRS profit for the period reached RMB 3.57 billion, up 35% year-on-year, while net profit attributable to shareholders totaled RMB 2.596 billion, an increase of 27.45% year-on-year. Basic earnings per share stood at RMB 0.82.

As a leading innovative healthcare services company, JD Health responded to public demand by accelerating the improvement of health product and service supply quality in the first half of 2025, actively promoting AI-driven service model innovation, and committed to providing users with high-quality, accessible, and convenient health consumption and service experiences.

During the reporting period, the group's revenue reached RMB 35.3 billion, up 24.5% year-on-year. As of June 30, 2025, annual active users over the past 12 months exceeded 200 million, with daily consultation orders surpassing 500,000 in the first half of the year.

Revenue increased 23.7% from RMB 15.1 billion for the three months ended June 30, 2024, to RMB 18.6 billion for the three months ended June 30, 2025. The growth in total revenue was primarily driven by product revenue from the sale of pharmaceutical and health products, which increased 22.7% from RMB 23.9 billion for the six months ended June 30, 2024, to RMB 29.3 billion for the six months ended June 30, 2025.

The growth in product revenue was mainly driven by an increase in active users and additional purchases by users, the continuously improving online penetration rate of pharmaceutical and health product sales, and the enrichment of product categories.

Service revenue from online platforms, digital marketing, and other services increased 34.4% from RMB 4.4 billion for the six months ended June 30, 2024, to RMB 6.0 billion for the six months ended June 30, 2025. The growth in service revenue was primarily due to increased digital marketing service fees, mainly attributable to the growing number of advertisers on the platform, consistent with the continued growth in transactions on the platform.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10